CUSIP: 09072X101
Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
6,612,558
-
Share change
-
-300,286
-
Total reported value
-
$4,296,000
-
Price per share
-
$0.65
-
Number of holders
-
12
-
Value change
-
-$412,446
-
Number of buys
-
6
-
Number of sells
-
6
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q3 2016
-
Previous quarter:
Q1 2016
Recent filing periods for CUSIP 09072X101:
Institutional Holders of BIOPHARMX CORP - COM (BPMX) as of Q2 2016
As of 30 Jun 2016,
BIOPHARMX CORP - COM (BPMX) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,612,558 shares.
The largest 10 holders included
FRANKLIN RESOURCES INC, SABBY MANAGEMENT, LLC, RTW INVESTMENTS, LLC, VANGUARD GROUP INC, LPL Financial LLC, TENOR CAPITAL MANAGEMENT Co., L.P., KCG Holdings, Inc., TWO SIGMA SECURITIES, LLC, CITADEL ADVISORS LLC, and LADENBURG THALMANN FINANCIAL SERVICES INC.
This page lists
12
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.